Company News

The 3P® ENTERPRISE solution has been developed by bioMérieux to fully address the daily industrial challenges of Environmental Monitoring (EM). Developed and validated, in collaboration with major global pharmaceutical companies, 3P® ENTERPRISE provides an end-to-end solution that fully digitalizes and automates the EM process.

The French bioproduction sector – in the form of a top-tier industrial consortium led by bioMérieux, Novasep, Sanofi and Servier – announced the launch of immerscio.bio at the France Bioproduction 2022 Congress on April 7 and 8. immerscio.bio will cover the entire bioproduction chain, employing a range of innovative digital solutions to promote the understanding of processes and the ownership of professional practices.

bioMérieux, a world leader in the field of in vitro diagnostics, has won the 2022 Food Safety Innovation Award for Predictive Diagnostics from theInternational Association for Food Protection (IAFP).

bioMérieux, a world leader in the field of in vitro diagnostics since 1963, announces the launch of GENE-UP^® QUANT Salmonella, the first, and only, AOAC approved true non-enrichment quantification diagnostic for Salmonella.

bioMérieux, a world leader in the field of in vitro diagnostics, announces the approval of the cutting-edge diagnostic assay for the detection of pathogenic E. coli., a bacterium that is commonly found in the human gastrointestinal tract.